Missense mutation of amylin gene (S20G) in Japanese NIDDM patients

Diabetes

Volumn 45, Issue 9, 1996, Pages 1279-1281

  Sakagashira, Setsuya ^a   Sanke, Tokio ^a   Hanabusa, Tadashi ^a   Shimomura, Hiroko ^a   Ohagi, Shinya ^a   Kumagaye, Kumiko Y ^b   Nakajima, Kiichiro ^b   Nanjo, Kishio ^a  

^a WAKAYAMA UNIVERSITY   (Japan)

^b Saito Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; DNA FRAGMENT;

ADULT; AMINO ACID SEQUENCE; ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EARLY DIAGNOSIS; EXON; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0029818742     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.9.1279     Document Type: Article

References (11)

1. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cell. Proc Natl Acad Sci USA 84:3881-3885, 1987
2. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632, 1987
3. Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF: Islet amyloid polypeptide: a new β-cell secretory product related to islet amyloid deposits. J Biol Chem 265:4173-4176, 1990
4. Westermark P, Johnson KH, O'Brien TD, Betsholtz C: Islet amyloid polypeptide: a novel controversy in diabetes research. Diabetologia 35:297-303, 1992
5. Young A, Pittner R, Gedulin B, Vine W, Rink T: Amylin regulation of carbohydrate metabolism. Biochem Soc Trans 23:325-331, 1995
6. Nishi M, Sanke T, Seino S, Eddy RL, Fan YS, Byers MG, Shows TB, Bell GI, Steiner DF: Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization and evolutionary history. Mol Endocrinol 3:1775-1781, 1989
7. Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, Nishimura S, Kondo M, Nanjo K: Plasma islet amyloid polypeptide (amylin) levels and their response to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:129-132, 1991
8. Nishi M, Bell GI, Steiner DF: Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor in 25 type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:628-630, 1990
9. Lorenzo A, Razzaboni B, Weir GC, Yanker BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756-760, 1994
10. Westermark P, Engstrom U, Johnson KM, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87:5036-5040, 1990
11. Steiner DF, Ohagi S, Nagamatsu S, Bell GI, Nishi M: Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes? Diabetes 40:305-309, 1991